Why Investors Shouldn't Be Surprised By Avacta Group Plc's (LON:AVCT) 26% Share Price Plunge
Feb 19
Have your own idea? Try our Stock Screener
U.K. (FTSE) Biotech Industry Analysis
UpdatedFeb 19, 2025
DataAggregated Company Financials
Companies23
- 7D-0.7%
- 3M-2.2%
- 1Y-11.5%
- YTD-1.7%
Last week, the Biotech industry hasn't moved much but Faron Pharmaceuticals Oy is up 6.9% in that time. As for the longer term, the industry has declined 11% in the last year. Earnings are forecast to grow by 39% annually.
Industry Valuation and Performance
Has the U.K. Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Thu, 20 Feb 2025 | UK£2.7b | UK£841.7m | -UK£294,154,841.09 | 84.5x | -9x | 3.2x |
| Sat, 18 Jan 2025 | UK£2.7b | UK£842.7m | -UK£297,323,030.32 | 85.2x | -9.2x | 3.2x |
| Mon, 16 Dec 2024 | UK£2.6b | UK£841.7m | -UK£294,234,688.84 | 79.2x | -9x | 3.1x |
| Wed, 13 Nov 2024 | UK£2.8b | UK£840.7m | -UK£293,766,111.71 | 88x | -9.6x | 3.3x |
| Fri, 11 Oct 2024 | UK£2.9b | UK£840.2m | -UK£295,657,028.93 | 97.4x | -10x | 3.5x |
| Sun, 08 Sep 2024 | UK£2.7b | UK£830.5m | -UK£314,446,085.32 | 82.9x | -8.7x | 3.3x |
| Tue, 06 Aug 2024 | UK£2.6b | UK£838.2m | -UK£257,829,540.40 | 30.2x | -9.9x | 3x |
| Thu, 04 Jul 2024 | UK£2.5b | UK£835.6m | -UK£260,780,212.79 | 30.1x | -9.8x | 3.1x |
| Sat, 01 Jun 2024 | UK£3.0b | UK£836.3m | -UK£287,266,028.40 | 30.6x | -10.3x | 3.6x |
| Mon, 29 Apr 2024 | UK£3.1b | UK£895.9m | -UK£215,717,681.40 | 29.7x | -14.4x | 3.5x |
| Wed, 27 Mar 2024 | UK£3.1b | UK£903.1m | -UK£202,183,517.28 | 28.5x | -15.4x | 3.5x |
| Fri, 23 Feb 2024 | UK£3.2b | UK£913.3m | -UK£197,835,821.65 | 31.2x | -16.2x | 3.5x |
| Sun, 21 Jan 2024 | UK£6.4b | UK£1.3b | -UK£245,297,001.00 | 37.3x | -25.9x | 5x |
| Tue, 19 Dec 2023 | UK£6.1b | UK£1.3b | -UK£245,590,728.00 | 37x | -25x | 4.8x |
| Thu, 16 Nov 2023 | UK£6.5b | UK£1.3b | -UK£242,394,041.00 | 39.3x | -26.6x | 5.1x |
| Sat, 14 Oct 2023 | UK£6.6b | UK£1.3b | -UK£251,319,262.00 | 38.4x | -26.1x | 5.1x |
| Mon, 11 Sep 2023 | UK£6.5b | UK£1.3b | -UK£207,007,212.00 | 23.6x | -31.6x | 5.1x |
| Wed, 09 Aug 2023 | UK£6.8b | UK£1.3b | -UK£209,217,365.00 | 23.4x | -32.5x | 5.4x |
| Fri, 07 Jul 2023 | UK£6.7b | UK£1.3b | -UK£209,039,838.00 | 23.9x | -32x | 5.3x |
| Sun, 04 Jun 2023 | UK£7.0b | UK£1.3b | -UK£204,603,564.00 | 22.6x | -34.3x | 5.6x |
| Tue, 02 May 2023 | UK£7.1b | UK£1.3b | -UK£205,973,036.00 | 23.6x | -34.3x | 5.6x |
| Thu, 30 Mar 2023 | UK£7.1b | UK£1.2b | -UK£155,047,316.00 | 24x | -45.7x | 5.7x |
| Sat, 25 Feb 2023 | UK£7.4b | UK£1.2b | -UK£156,973,587.00 | 26.1x | -47.4x | 6x |
| Mon, 23 Jan 2023 | UK£7.7b | UK£1.2b | -UK£139,964,852.00 | 27.7x | -54.7x | 6.6x |
| Wed, 21 Dec 2022 | UK£7.4b | UK£1.2b | -UK£138,103,865.00 | 26.7x | -53.3x | 6.3x |
| Fri, 18 Nov 2022 | UK£7.8b | UK£1.2b | -UK£140,671,510.00 | 25.1x | -55.1x | 6.7x |
| Sun, 16 Oct 2022 | UK£7.0b | UK£1.2b | -UK£150,681,291.00 | 26.2x | -46.7x | 6.1x |
| Tue, 13 Sep 2022 | UK£7.6b | UK£1.1b | -UK£144,420,164.00 | 35.4x | -52.4x | 6.6x |
| Thu, 11 Aug 2022 | UK£7.4b | UK£1.1b | -UK£199,848,602.00 | 37.2x | -36.8x | 6.6x |
| Sat, 09 Jul 2022 | UK£7.1b | UK£1.1b | -UK£175,037,886.00 | 36.3x | -40.4x | 6.3x |
| Mon, 06 Jun 2022 | UK£7.1b | UK£1.1b | -UK£156,906,832.00 | 37.9x | -45.5x | 6.4x |
| Wed, 04 May 2022 | UK£7.2b | UK£1.1b | -UK£139,598,748.00 | 35x | -51.9x | 6.5x |
| Fri, 01 Apr 2022 | UK£7.3b | UK£1.1b | -UK£87,768,925.00 | 41.4x | -83.6x | 6.7x |
| Sun, 27 Feb 2022 | UK£7.7b | UK£1.1b | -UK£130,231,992.00 | 32.8x | -59.4x | 7.1x |
Price to Earnings Ratio
-59.4x
Current Industry PE
- Investors are pessimistic on the British Biotechs industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The 3-year average PS ratio of 5.5x is higher than the industry's current PS ratio of 3.2x.
Past Earnings Growth
- The earnings for companies in the Biotechs industry have deteriorated over the last three years.
- Revenues have also declined 8.2% per year.
- This means overall sales from these companies are declining and losses are subsequently expanding as well.
Industry Trends
Which industries have driven the changes within the U.K. Healthcare industry?
| GB Market | -0.17% | |
| Healthcare | 0.94% | |
| Biotech | -0.69% | |
| Biotech | -0.69% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| FARN Faron Pharmaceuticals Oy | UK£1.70 | 6.9% +UK£11.5m | 30.8% | PB155.8x | |
| BVXP Bioventix | UK£29.00 | 5.5% +UK£7.8m | -42.7% | PE18.7x | |
| SBTX SkinBioTherapeutics | UK£0.21 | 14.5% +UK£6.0m | 97.6% | PS39.2x | |
| PRTC PureTech Health | UK£1.46 | 1.0% +UK£3.4m | -21.9% | PS939x | |
| OPTI OptiBiotix Health | UK£0.17 | 14.8% +UK£2.2m | -22.2% | PS30.1x |